ABSTRACT
BACKGROUND: We conducted a randomized controlled trial to evaluate the effectiveness of acceptance and commitment therapy (ACT) delivered via a mobile phone messaging robot to patients who had their total hip arthroplasty or total knee arthroplasty procedures postponed due to the COVID-19 pandemic. METHODS: Ninety patients scheduled for total hip arthroplasty or total knee arthroplasty who experienced surgical delay due to the COVID-19 pandemic were randomized to the ACT group, receiving 14 days of twice daily automated mobile phone messages, or the control group, who received no messages. Minimal clinically important differences (MCIDs) in preintervention and postintervention patient-reported outcome measures were utilized to evaluate the intervention. RESULTS: Thirty-eight percent of ACT group participants improved and achieved MCID on the Patient-Reported Outcome Measure Information System Physical Health compared to 17.5% in the control group (P = .038; number needed to treat [NNT] 5). For the joint-specific Hip Disability and Osteoarthritis Outcome Score Joint Replacement and Knee Disability and Osteoarthritis Outcome Score Joint Replacement (KOOS JR), 24% of the ACT group achieved MCID compared to 2.5% in the control group (P = .004; NNT 5). An improvement in the KOOS JR was found in 29% of the ACT group compared to 4.2% in the control group (P = .028; NNT 5). Fourteen percent of the ACT group participants experienced a clinical important decline in the KOOS JR compared to 41.7% in the control group (P = .027; NNT 4). CONCLUSION: A psychological intervention delivered via a text messaging robot improved physical function and prevented decline in patient-reported outcome measures in patients who experienced an unexpected surgical delay during the COVID-19 pandemic. LEVEL OF EVIDENCE: 1.
Subject(s)
Acceptance and Commitment Therapy , Arthroplasty, Replacement, Hip , COVID-19 , Cell Phone , Osteoarthritis, Knee , Humans , Osteoarthritis, Knee/surgery , Pandemics , SARS-CoV-2ABSTRACT
Background: As the population ages, rate of total knee arthroplasty increases and thus, it is important to maximize efficiency and minimize risk. Identifying patients who are at higher risk for transfusion can help streamline care provided and minimize superfluous, costly hemoglobin monitoring in low risk patients. Methods: Adult patients who underwent total knee arthroplasty (TKA) in 2015 were identified in the National Surgical Quality Improvement Project (NSQIP) database. Patients were divided into two cohorts: those who required transfusion post operatively and those who did not. Patient demographics and comorbidities were compared using univariate analysis; and multivariate analysis was used to determine risk factors for short-term complications. Results: Of 48,055 TKA patients, 3.0% required transfusion. The patients who required transfusion were older, had higher BMI, higher rates of comorbidities and were more frequently ASA class 3-4 (p<0.005). Univariate analysis revealed that patients who required transfusion had higher rates of any complication (9.19% v. 4.23%, p<0.001). Multivariate regression analysis identified the following as risk factors for transfusion requirement: Black race (adjusted odds ratio [OR] 1.2, 95% confidence interval [CI] 1.01-1.4), COPD (OR 1.6, 95% CI 1.3-2.0), corticosteroids (OR 1.4, 95% CI 1.1-1.8), bleeding disorder (OR 1.4, CI 1.1-1.9), ASA class 4 (OR 2.3, CI 1.5-4.8), operative time >2 hours (OR 1.3, 95% CI 1.2-1.5) and lack of functional independence (OR 1.6, 95% CI 1.1-2.3). Conclusions: In a cohort of patients undergoing primary TKA in 2015, history of COPD, black race, operative time, steroid use, bleeding disorder, lack of functional independence and ASA class 3-4 were independent predictors of need for blood transfusion. Additionally, we found that patients who received transfusion demonstrated a significantly higher rate of the following: any complication, pneumonia, urinary tract infection, septic shock, deep vein thrombosis, renal insufficiency, cardiac arrest, myocardial infarction, unplanned readmission, reoperation and mortality. Presence of these risk factors in TKA patients could represent an indication for hemoglobin monitoring post-operatively.Level of Evidence: IV.
Subject(s)
Arthroplasty, Replacement, Knee/statistics & numerical data , Blood Transfusion/statistics & numerical data , Aged , Cohort Studies , Female , Humans , Male , Middle Aged , Postoperative Period , Risk Factors , United StatesABSTRACT
The ideal treatment for unstable thoracolumbar fractures remains controversial with posterior reduction and stabilization, anterior reduction and stabilization, combined posterior and anterior reduction and stabilization, and even nonoperative management advocated. Short segment posterior osteosynthesis of these fractures has less comorbidities compared with the other operative approaches but settles into kyphosis over time. Biomechanical comparison of the divergent bridge construct versus the parallel tension band construct was performed for anteriorly destabilized T11-L1 spine segments using three different models: (1) finite element analysis (FEA), (2) a synthetic model, and (3) a human cadaveric model. Outcomes measured were construct stiffness and ultimate failure load. Our objective was to determine if the divergent pedicle screw bridge construct would provide more resistance to kyphotic deforming forces. All three modalities showed greater stiffness with the divergent bridge construct. The FEA calculated a stiffness of 21.6 N/m for the tension band construct versus 34.1 N/m for the divergent bridge construct. The synthetic model resulted in a mean stiffness of 17.3 N/m for parallel tension band versus 20.6 N/m for the divergent bridge (p = 0.03), whereas the cadaveric model had an average stiffness of 15.2 N/m in the parallel tension band compared with 18.4 N/m for the divergent bridge (p = 0.02). Ultimate failure load with the cadaveric model was found to be 622 N for the divergent bridge construct versus 419 N (p = 0.15) for the parallel tension band construct. This study confirms our clinical experience that the short posterior divergent bridge construct provides greater stiffness for the management of unstable thoracolumbar fractures.
ABSTRACT
Ischemia and reperfusion represent major mechanisms of tissue injury and organ failure. The timing of administration and the duration of action limit current treatment approaches using pharmacological agents. In this study, we have successfully developed a preemptive strategy for tissue protection using an adenoassociated vector system containing erythropoietin hypoxia response elements for ischemia-regulated expression of the therapeutic gene human heme-oxygenase-1 (hHO-1). We demonstrate that a single administration of this vector several weeks in advance of ischemia/reperfusion injury to multiple tissues such as heart, liver, and skeletal muscle yields rapid and timely induction of hHO-1 during ischemia that resulted in dramatic reduction in tissue damage. In addition, overexpression of therapeutic transgene prevented long-term pathological tissue remodeling and normalized tissue function. Application of this regulatable system using an endogenous physiological stimulus for expression of a therapeutic gene may be a feasible strategy for protecting tissues at risk of ischemia/reperfusion injury.